Blog
What's Next for These 3 E-Commerce Stocks as the Economy Reopens?
Many e-commerce companies have enjoyed huge tailwinds amid the coronavirus pandemic, with social distancing prompting consumers to do their shopping through online channels and driving record sales
3 Steps to Becoming a Stock Market Multimillionaire
Becoming a multimillionaire is a dream many people share but few ever achieve. The good news is that it's possible for the average investor to become one.
Getting rich in the stock market may seem
These Banks Could Be Big Winners in 2021
When we hear about bank stocks in the news, companies like JPMorgan Chase (NYSE: JPM) and Bank of America (NYSE: BAC) tend to get the most coverage. But they aren't necessarily going to have the
3 Top Dividend Stocks to Buy Right Now
Are you ready to take a break from searching for the market's next great growth stories? You wouldn't be wrong to do so, and you certainly wouldn't be alone. Everyone needs to take a step back
3 Stocks to Buy and Hold for the Next 10 Years
When you decide to marry, your wedding vow may go something like this: "I take you to have and to hold from this day forward, for better, for worse, for richer, for poorer, in sickness and in
Is SoFi the Growth Stock for You?
The online lender SoFi, which will soon go public through Chamath Palihapitiya's blank-check company Social Capital Hedosophia Holdings Corp. V (NYSE: IPOE), has some pretty ambitious growth plans
Which Stock Is Likely to Be the Biggest Winner: Lilly, Vir, or GlaxoSmithKline?
GlaxoSmithKline (NYSE: GSK), Vir Biotechnology (NASDAQ: VIR), and Eli Lilly (NYSE: LLY) recently reported positive results from a phase 2 study evaluating a combination of Lilly's bamlanivimab with
Could This EV Stock Be the Next Tesla?
Tesla (NASDAQ: TSLA) has been a magnet for attention, and criticism, in recent years, but it is hard to argue with the results.
Shares of the electric vehicle maker are up more than 1,000% over the
Okta's Addressable Market Is Getting Even Bigger
Okta (NASDAQ: OKTA) is set to cross the $1 billion revenue mark this year, but in some ways the identity-for-the-cloud specialist still looks like a small fish in a big pond.
That's because the
This Tech Dinosaur Just Took a Game-Changing Step in Healthcare
Quantum physics sounds like science fiction to most people. That's because until recently, it has been largely theoretical. It describes the behavior of atoms and fundamental particles, and asserts
1 Healthcare ETF Proven To Strengthen Your Portfolio
In horse racing, to bet the field means to place a single bet on all of the entrants as one, not including the horse with the best odds to win. But in investing, if you're using odds in your
1 Healthcare ETF Proven to Strengthen Your Portfolio
In horse racing, to bet the field means to place a single bet on all of the entrants as one, not including the horse with the best odds to win. But in investing, if you're using odds in your
1 Fintech That Could Be a Long-Term Winner
Although it isn't even public yet, fintech start-up SoFi is making some big moves. It recently acquired a bank and also announced its plans to bring IPO investing -- historically available only to
3 Things to Do Now If You're Retiring in the Next Decade
If you plan to retire within the next 10 years, it's time to start getting serious about preparing for a future without a paycheck.
You'll need a hefty retirement account to support you, and you
The Story of COVID-19, Tax Revenue, and the Green Wave
For American multistate operators like Curaleaf Holdings (OTC: CURLF) and Green Thumb Industries (OTC: GTBIF), the illegal status of cannabis at the federal level poses severe restrictions on how
Why Has the SPAC Market Cooled Off So Fast?
In some weeks so far in 2021, more than 30 new SPACs (special purpose acquisition companies) have come onto the market. More than 400 of these blank-check companies are still looking for deals
3 Top Healthcare Stocks to Buy in April
Between scientific innovation, new business models, and a resurging global economy, there's a tremendous amount of opportunity in the healthcare sector right now. In a way, that makes the process of
Forget Meme Stocks. Put Your Money Here Instead
Like it or not, social media has the potential to influence a lot of people -- but that doesn't mean you should let it dictate how you invest your money. These days, there's a lot of buzz about meme
A Stock Market Crash May Be Imminent: 3 Things to Do Right Now
What I'm about to say is going to unnerve some of you, but it's the absolute truth: A stock market crash might be imminent.
Since hitting a bear-market bottom on March 23, 2020, the three major U.S
3 Stocks That Could Suffer if Biden Gives In to This Pressure
A proposal currently before the World Trade Organization would waive patent rights on COVID-19 vaccines and treatments in an effort to help low-income nations. Several top Democrats appear to
3 Top Healthcare Growth Stocks to Buy for April
Healthcare stocks have become increasingly popular with investors since the onset of the COVID-19 pandemic. Before 2020, few would have expected that investing in vaccine developers, telehealth
This Genius Move Has All but Guaranteed NVIDIA's Role in the Future of Tech
Many investors can easily identify NVIDIA (NASDAQ: NVDA) as a specialized semiconductor company. The company launched its first product, a 2D/3D graphics card, in 1995. Later that year, NVIDIA
1 Great Stock You Can Buy on Sale Right Now
Most high-growth technology stocks are well off their highs, and Latin American e-commerce and fintech giant MercadoLibre (NASDAQ: MELI) is no exception. In this Fool Live video clip, recorded on
Could Celldex Be a Millionaire-Maker Stock?
Biotechs are some of the riskiest -- and sometimes the most rewarding -- investments around, and for good reason. Buying a stock in a totally unproven company that doesn't even have a product or any
Adult-Use vs. Medical Cannabis Markets: What Investors Need to Know
The marijuana sector is rapidly evolving. Although the drug is still illegal at the federal level, 16 states and Washington, D.C. have approved the drug for adult-use, and over 30 states have


